Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
In our round-up of recent #biotech financings, Aardvark Therapeutics is reported to be planning an IPO, while @Obsidian_Tx, @AlteromeTx, and Diagonal Therapeutics all complete nine-figure private rounds https://t.co/Tm5CSBLgtN
Venture report: Obsidian, Alterome and Diagonal all raised nine-figure megarounds this week, plus Perceptive Xontogeny backed Switzerland-based schizophrenia play Neurosterix https://t.co/kKLRbIaQcD
Biotech PIPE party — more than $5B raised in Q1. @BioCentury's @StephenPHansen tallies the leading investors in 1Q24's record setting PIPE haulhttps://www.biocentury.com/article/651993
Biotechnology firm Alterome Therapeutics has successfully raised $132 million in a series B financing round led by Goldman Sachs Alternatives. This funding is part of a significant trend in the biotech industry, with several other companies also securing substantial investments in the same period.